1-(4-Methoxyphenyl)piperazine - CAS 38212-30-5
Catalog: |
BB023582 |
Product Name: |
1-(4-Methoxyphenyl)piperazine |
CAS: |
38212-30-5 |
Synonyms: |
1-(4-methoxyphenyl)piperazine |
IUPAC Name: | 1-(4-methoxyphenyl)piperazine |
Description: | 1-(4-Methoxyphenyl)piperazine (CAS# 38212-30-5) is a useful research chemical. |
Molecular Weight: | 192.26 |
Molecular Formula: | C11H16N2O |
Canonical SMILES: | COC1=CC=C(C=C1)N2CCNCC2 |
InChI: | InChI=1S/C11H16N2O/c1-14-11-4-2-10(3-5-11)13-8-6-12-7-9-13/h2-5,12H,6-9H2,1H3 |
InChI Key: | MRDGZSKYFPGAKP-UHFFFAOYSA-N |
Boiling Point: | 344 °C at 760 mmHg |
Melting Point: | 42-47 °C |
Purity: | > 98 % |
Density: | 1.057 g/cm3 |
Appearance: | White powder, crystals, crystalline powder and/or chunks |
Storage: | Store in a cool, dry place. Keep container closed when not in use. |
MDL: | MFCD00040736 |
LogP: | 1.49860 |
GHS Hazard Statement: | H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] |
Precautionary Statement: | P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
CN-112876418-A | Acetamide derivative and application thereof in antitumor and antitumor drug preparation | 20201230 |
CN-112608275-A | Application of 2, 8-bis (trifluoromethyl) -4-hydroxyquinoline derivative in preparation and prevention and treatment of agricultural diseases | 20201229 |
CN-112341396-A | Novel monoacylglycerol esterase inhibitor and preparation method and application thereof | 20201104 |
CN-111879767-A | Color development test method of piperazine novel mental active substance | 20200729 |
CN-111795963-A | Method for chromogenic detection of piperazine novel psychotropic active substances | 20200729 |
PMID | Publication Date | Title | Journal |
26821219 | 20161201 | Hepatotoxicity of piperazine designer drugs: up-regulation of key enzymes of cholesterol and lipid biosynthesis | Archives of toxicology |
26344803 | 20151201 | Structure-dependent inhibition of the human α1β2γ2 GABAA receptor by piperazine derivatives: A novel mode of action | Neurotoxicology |
22071119 | 20120501 | Piperazine compounds as drugs of abuse | Drug and alcohol dependence |
22221903 | 20120305 | Determination of piperazine-type stimulants in human urine by means of microextraction in packed sorbent and high performance liquid chromatography-diode array detection | Journal of pharmaceutical and biomedical analysis |
22412599 | 20120301 | 10α-Hy-droxy-13-{[4-(4-meth-oxy-phen-yl)piperazin-1-yl]meth-yl}-4,9-dimethyl-3,8,15-trioxatetra-cyclo-[10.3.0.0.0]penta-decan-14-one | Acta crystallographica. Section E, Structure reports online |
Complexity: | 161 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 192.126263138 |
Formal Charge: | 0 |
Heavy Atom Count: | 14 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 192.126263138 |
Rotatable Bond Count: | 2 |
Topological Polar Surface Area: | 24.5 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 1.2 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Piperazines
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS